Mark De Rosch - 11 Feb 2026 Form 4 Insider Report for CervoMed Inc. (CRVO)

Role
EVP, RA and GA and PgM
Signature
/s/ William R. Elder, attorney-in-fact for the Reporting Person
Issuer symbol
CRVO
Transactions as of
11 Feb 2026
Net transactions value
$0
Form type
4
Filing time
13 Feb 2026, 17:01:12 UTC
Previous filing
23 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
De Rosch Mark EVP, RA and GA and PgM C/O CERVOMED INC., 20 PARK PLAZA, SUITE 424, BOSTON /s/ William R. Elder, attorney-in-fact for the Reporting Person 13 Feb 2026 0001890320

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRVO Stock Option (Right to Buy) Award $0 +30,000 $0.000000 30,000 11 Feb 2026 Common Stock 30,000 $4.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing February 28, 2026.